Header Logo

Connection

MALCOLM BRENNER to Bortezomib

Back to Details
This is a "connection" page, showing publications MALCOLM BRENNER has written about Bortezomib.
MALCOLM BRENNER
Connection Strength
0.026
Bortezomib
  1. Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity. Cancer Gene Ther. 2014 Nov; 21(11):472-482.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.